Departmental Seminar Series: Dr. Jonathan Loree, University of British Columbia
Departmental Seminar
Speaker: Dr. Jonathan Loree
Institution: University of British Columbia | BC Cancer
Title: “Optimizing Outcomes in Colorectal Cancer with Circulating Tumor DNA (ctDNA) Across the Entire Cancer Journey.”
Date: Thursday, March 20th, 2025
Time: 1:00 PM EST
Host: Dr. Philip Awadalla
Location: OICR WEST RM 5-20
or
Zoom: https://utoronto.zoom.us/j/81860204900
Meeting ID: 818 6020 4900 Passcode: 992198
Bio: Jon Loree is a medical oncologist at BC Cancer, Associate Professor at The University of British Columbia and Senior Investigator at CCTG with an interest in GI malignancies. He completed his medical oncology fellowship at BC Cancer and subsequently undertook a translational research fellowship at MD Anderson where he completed a Master of Science. His research focus is translational research and biomarker development in colorectal cancer and neuroendocrine neoplasms. He serves as the NCI Colon Cancer Task Force Co-Chair and is a member of the ASCO Evidence Based Medicine Committee.
Abstract: Circulating tumour DNA (ctDNA) holds tremendous promise for transforming patient outcomes in colorectal cancer. However, its ability to drive progress and improve survival depends on proper implementation and clinical integration. We’ll explore the diverse applications of ctDNA, from early detection to risk stratification for guiding adjuvant therapy to personalizing treatment for metastatic disease. We will also discuss current challenges and possible solutions to support integrating this technology into the Canadian healthcare system.